Drug Type Small molecule drug |
Synonyms IMIDAZOLYL ETHANAMIDE PENTANDIOIC ACID, Vitaglutam + [2] |
Target- |
Mechanism Apoptosis inhibitors, Granulocytes stimulants, Haematopoiesis stimulants + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date RU (01 Jan 2009), |
Regulation- |
Molecular FormulaC10H15N3O3 |
InChIKeyKZIMLUFVKJLCCH-UHFFFAOYSA-N |
CAS Registry219694-63-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Virus Diseases | RU | 17 Jul 2014 | |
Influenza, Human | RU | - | 01 Jan 2009 |
Neutropenia | RU | - | 01 Jan 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | RU | 06 Oct 2021 | |
Bone marrow depression | Phase 2 | DE | 01 Mar 2016 | |
Breast Cancer | Phase 2 | DE | 01 Mar 2016 | |
Cervical Intraepithelial Neoplasia | Phase 2 | DE | 01 Mar 2016 | |
Chemotherapy-Induced Febrile Neutropenia | Phase 2 | DE | 01 Mar 2016 | |
Acute respiratory infections | Phase 2 | RU | 03 Oct 2010 | |
Common Cold | Phase 2 | RU | 03 Oct 2010 | |
Common Cold | Phase 2 | RU | 03 Oct 2010 | |
Influenza, Human | Phase 2 | RU | 03 Oct 2010 | |
Viral respiratory infection | Phase 2 | RU | 03 Oct 2010 |
Phase 2 | - | (rrtudzbahk) = reduced qwfzrsrxzt (mvvjljwslo ) View more | - | 25 May 2020 | |||
(Control) | |||||||
NCT02692742 (ASCO2019) Manual | Phase 2 | 130 | gakamxylcs(utrouztoyt) = jycgtioxev rkmowgfpnf (fxgwtetxls, 12.6 - 14.5) View more | Positive | 31 May 2019 | ||
placebo | gakamxylcs(utrouztoyt) = ywbitvknjw rkmowgfpnf (fxgwtetxls, 13.0 - 14.9) View more |